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Abstract: Natural bioactive compounds have been found superior to chemical compounds for use in pharmaceutical applications.
Such natural compounds include biologically active compounds present as a part of fungal metabolism that originate through different
biochemical pathways and contain different structural groups like benzopyranones, phenols, toxins, and steroids. One such novel
compound is a secondary metabolite extracted from the filamentous fungus Aspergillus japonicus Saito. The compound exhibited
anticancer properties and was found to be harmless to normal human lymphocytes. The metabolites were separated by thin layer
chromatography and screened for their cytotoxic potential through 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay
in the cervical cancer cell line HeLa. Induction of apoptosis in the treated cervical cancer cell line HeLa was observed and confirmed
through fluorescence microscopy, DNA fragmentation analysis, and caspase-3-enzyme activity assays. Preliminary chemical screening
carried out indicated the presence of alkaloids in the bioactive fraction. The bioactive fraction was subjected to LC-MS analysis for
characterization. This study indicated that the metabolite shows promise for use as an antineoplastic agent. This is the first report of an
anticancer compound from A. japonicus.
Key words: Aspergillus japonicus, secondary metabolite, anticancer, HeLa cells, apoptosis, alkaloid

1. Introduction
Filamentous fungi have been exploited for their use as
producers of novel secondary metabolites (Calvo et al.,
2002). Secondary metabolites have been shown to be
useful anticancer agents and their natural origin makes
them superior to products of chemical origin (Kinghorn
et al., 2009). They have often been used in the treatment
of cancer and are important as antineoplastic agents.
As cancer affects a huge percentage of the population
and 41% of cancer deaths in women are due to cervical,
stomach, and breast cancers (Ali et al., 2011), the search
for novel drugs is still a priority goal for cancer therapy. In
addition, the high toxicity usually associated with cancer
chemotherapy drugs and their undesirable side effects
increase the demand for novel antitumor drugs active
against untreatable tumors, with fewer side effects and/or
with greater therapeutic efficiency (Demain and Sánchez,
2009). Considering this as the main goal, we have isolated
a number of filamentous fungi from various soil sources.
Among the isolates, Aspergillus japonicus Saito was chosen
for our study. A. japonicus is a fungus that belongs to the
class Ascomycetes. They have produced many secondary
metabolites that have been used to treat various diseases
* Correspondence: varalakshmikn@yahoo.co.in
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(Calton et al., 1978, El-Kassas et al., 2009). Aspergillus
spp. are also known to possess biological activities such
as antitumor, antibacterial, antifungal, and immune
potentiating activities (Selim et al., 2012; Demain and
Sánchez, 2009).
The aim of the present study was to analyze the potential
anticancer activity of the secondary metabolite extracted
from A. japonicus on the cervical cancer cell line HeLa
and to evaluate its safety in humans by testing on normal
human peripheral lymphocytes. We also tried to partially
purify and characterize the active compound responsible
for the anticancer activity by thin layer chromatography
(TLC) and liquid chromatography–mass spectrometric
(LC-MS) analyses.
2. Materials and methods
2.1. Fungal isolation and identification
The filamentous fungus A. japonicus Saito was isolated
from the soil source in Bangalore, Karnataka. This fungus
was stained using Lactophenol cotton blue and identified.
It was then sent to Agharkar Research Institute, Pune,
for identification. Colonies of the fungus were grown
on Czapek Dox Agar plates and fungal mats cultured
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on Czapek Dox Broth media (HIMEDIA) at room
temperature. These mats were used as a source for the
extraction of the secondary metabolites.
2.2. Extraction and purification of secondary metabolites
For extraction of the bioactive compound, 20 mL of
48-h-old culture of A. japonicus was prepared by incubating
an active mycelial mat in 50 mL of Czapek Dox broth in
250-mL Erlenmeyer flasks at 25 °C in a rotary shaker (150
rpm). The enriched cultures (10 mL) were transferred as
seed into each of 20 Erlenmeyer flasks (250 mL) containing
100 mL of Czapex Dox Broth medium and incubated for
8 days at 25 °C in stationary condition. To isolate the
bioactive metabolites, the mycelial mass was separated by
filtration through Whatman filter paper (No. 1) and the
mat was dried in a hot air oven at 60 °C for 24 h. The dried
hyphae were homogenized and the metabolites extracted
with methanol, applying standard methods (Joshi et al.,
2003). The extract from the mycelia was evaporated under
vacuum at 50 °C till dryness. The obtained solid material
was weighed and dissolved in dimethyl sulfoxide (DMSO)
to form the crude extract at 1 mg/mL concentration.
Separation of secondary metabolites from the crude
extract was carried out by TLC using chloroform:acetone
(1:1) as the solvent. TLC was carried out using pre-coated
TLC plates silica gel 60 F 254 (Merck). The TLC sheet was
activated at 110 °C for 15 min. The fungal extract dissolved
in methanol (20 µL) was spotted at the bottom of a silica
gel coated sheet. The chromatograms were detected with
the help of a UV transilluminator (254 and 366 nm) and
the Rf value of the fractions separated on the TLC plate
were determined. Rf value = movement of solute from
the origin/movement of solvent from the origin. Different
fractions were separated and collected in different vials by
dissolving with 1 mL of methanol. The tubes were then
vortexed gently and centrifuged at 10,000 rpm for 5 min.
The supernatant was transferred into pre-weighed vials
and evaporated to dryness in a rotary evaporator. Extract
concentration was maintained at 1 mg/mL (stock solution)
by dissolving in DMSO.
2.3. Cell lines and maintenance
The HeLa cell line was procured from the National Center
for Cell Sciences (NCCS), Pune. For maintaining the cell
lines, DMEM, i.e. Dulbecco’s Modified Eagle Medium
(HIMEDIA; REF – AT065A) and 10% Fetal Bovine Serum
(HIMEDIA; REF – RM112) were used, supplemented with
20 mM L-glutamine and 7.5% sodium bicarbonate.
2.4. Screening for cytotoxic potential
Both lymphocyte and HeLa cells were treated with the crude
extract and were subjected to MTT assay for assessing the
cytotoxicity of the extract. After trypsinization 24-h-old
cultures of HeLa cells and lymphocytes were harvested
and 100 µL of the media containing the cells were

transferred to each of the wells of a 96-well microtiter plate
and incubated overnight at 37 °C with 5% CO2. This was
followed by the addition of different concentrations (12.5,
25, 50, 75, and 100 µg/mL) of fungal extract in DMSO for
24, 48, and 72 h. The final concentration of DMSO was
maintained at 0.4% of the media in each well. Control
HeLa and lymphocytes were treated with only DMSO
(not exceeding 0.4%) in place of the extracts. Then 10 µL
of MTT dye was added to each well and the plates were
incubated for 3 h in a dark chamber. After this, 100 µL of
solubilizing solution (DMSO) was added to each well and
the absorbance was recorded at 540 nm using an ELISA
plate reader (Mosmann, 1983). The experiments were
performed in quadruplicate. The percentage viability was
calculated from the following formula:
Percentage viability (%) = (A540 of the test sample)/
(A540 of the control) × 100
2.5. Detection of bioactive compound
Bioassay guided fractionation was followed for the
detection of active compound separated in TLC. The
partially purified fractions obtained from preparative
TLC were tested for cytotoxicity against HeLa cells and
lymphocytes by MTT assay as described earlier.

2.6. Apoptosis determination by fluorescence microscopy
HeLa cells growing exponentially were subcultured to 25cm2 culture flasks and allowed to adhere for 24 h. They
were then treated with the bioactive fraction for 24 h. The
cells treated with the fraction were washed 3 times with
phosphate buffer saline (PBS), trypsinized, and centrifuged
at 1000 rpm for 10 min. The supernatant was discarded
and cells were resuspended in 2 mL of PBS. About 10 µL
of the stain (stock solution of ethidium bromide:acridine
orange prepared separately and mixed in 1:1 ratio) was
mixed with 10 µL of cells suspended in PBS (Cohen,
1993). Stained cells were used to prepare the slides and
observed under a fluorescence microscope (Labomed,
Germany) using a blue-green filter. Control HeLa cells
treated with DMSO were also simultaneously processed
for fluorescence microscopy.
2.7. Caspase-3 apoptotic assay
After treating HeLa cells with the bioactive fraction for
24 h, the assay was carried out using 2X CasPASE from
(G-Biosciences). Controls HeLa cells were treated with
DMSO at 0.4%. To the wells of a microtiter plate, 50 µL
of 2X CasPASE assay buffer was added, followed by 50 µL
of bioactive fraction treated cell suspension. The contents
were mixed thoroughly and 5 µL of 1 mM AFC-conjugated
substrate was added to each well. Optical density was
recorded in an ELISA plate reader (405 nm) at zero
time point and thereafter every 15 min, until significant
differences in the readings were observed.
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2.9. Chemical screening
Preliminary chemical screening was carried out for the
crude extract and the bioactive fraction using standard
procedures (Harborne, 1973) to test for the presence of
reducing sugars, saponins, alkaloids, steroids, proteins,
tannins, phenols, flavonoids, and glycosides. In the case of
tests for reducing sugars, Benedict’s and Fehling’s tests were
carried out. Tests for the detection of alkaloids (Wagner’s
and Mayer’s tests), test for sterols (Salkowsky test), tests for
the detection of tannins and phenolic compounds, tests
for peptides and proteins (Biuret test and Lowry’s test),
and tests for the detection of flavonoids (Shinoda test) and
saponins were performed.
2.10. LC-MS analysis of the bioactive fraction
To further characterize the bioactive fraction, it was
subjected to LC-MS analysis. The bioactive fraction was
subjected to high performance liquid chromatography
(HPLC). The HPLC separation was performed using a
WATERS HPLC system with 2487 dual λ U-V detector.
The sample and mobile phase were filtered through a
0.22-µm PVDF filter before injection into the column.
The HPLC fraction was further subjected to spectroscopic
analysis. ESI mass spectra were recorded using a single
quadrupole mass spectrometer (Hewlett Packard HP 1100
MSD series). Spectra were acquired over the mass range
50–1500 m/z.
2.11. Statistical analysis
All experiments were carried out in triplicate. The results
were calculated as mean ± standard error (SE) values.
Statistical significance was calculated using one-way
analysis of variance (ANOVA) to test the null hypothesis.
Duncan’s multiple range test (DMRT) was used to compare
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the sample means. The data were considered significantly
different from each other when significance level was P <
0.05 (Gomez and Gomez, 1984).
3. Results
3.1. Fungal isolation and identification
The fungus was morphologically identified as Aspergillus
sp. after staining with Lactophenol cotton blue and
observed under the microscope. It was identified as
Aspergillus japonicus Saito at Agharkar Research Institute,
Pune (pure culture deposited with an acquisition no.
AFCCI-2757). They were subcultured once every 5 days
and pure cultures were maintained on Potato Dextrose
Agar slants.
3.2. Screening for cytotoxic potential
When the crude extract was added to the HeLa cells at
5 different concentrations (12.5, 25, 50, 75, and 100 µg/
mL) viability decreased from 61.2% to 32.4% after 24
h and it further decreased to 22% after 72 h (Figure 1).
This indicated that the fungal extract has good cytotoxic
potential, with an IC50 value of < 25 µg/mL concentration.
3.3. Bioassay-guided identification of active fractions
Following methanol extraction of the fungal biomass,
the solvent was evaporated to obtain 330 mg of dried
extract. On TLC plates, separation of the crude extract
into different bioactive fractions was carried out using the
solvents chloroform:acetone in 1:1 ratio and 9 different
bands were obtained. The Rf values were calculated for
each of the fractions separated by TLC (Table 1).
When HeLa cells were treated with the different fractions
separated in TLC, fraction 8 showed the best cytotoxic
results out of all the tested fractions. Fraction 8 exhibited
the highest cytotoxic activity at 10 µg/mL (50.65%) and 20
120

control
24 h

100
Percentage viability (%)

2.8. DNA fragmentation assay
HeLa cells growing exponentially were subcultured to 25cm2 culture flasks and allowed to adhere for 24 h. They
were then treated with 10 µg/mL of the bioactive fraction
for 24 h. Control HeLa cells received DMSO at 0.4% in
place of the bioactive fraction. Cells were harvested by
trypsinization and subjected to DNA extraction. Then
200 µL of the above cell suspension was treated with 20
µL of RNase A solution and incubated for 2 min at room
temperature. Next 20 µL of proteinase K (20 mg/mL) and
200 µL of lysis buffer A were added, vortexed for 15 min,
and incubated in a hot water bath at 70 °C for 10 min. After
that, 200 µL of ice cold ethanol was added and the vials were
vortexed for 15 s. The vials were then centrifuged at 10,000
rpm for 10 min. The precipitated DNA was dissolved in 20
µL of Tris-EDTA (TE) buffer and 20 µL of gel loading dye
was added, followed by loading onto 0.8% agarose gel and
electrophoresis (Lee and Shacter, 1999). For comparison,
40 bp ladder DNA as well as DNA extracted from the
control HeLa cells was also subjected to electrophoresis.
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Figure 1. Effect of different concentrations of A. japonicus extract
on HeLa cell percent viability when treated for 24, 48, and 72
h. Vertical bars indicate SE of the mean for n = 4. *: P < 0.05 as
compared to the control. **: P < 0.01 as compared to the control.
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Table 1. Rf values and IC50 values of TLC purified fractions from
the methanol extract of A. japonicus.
Rf value

IC50 (μg/mL)

F1

0.08

-

F2

0.10

60

F3

0.14

-

F4

0.22

-

F5

0.34

-

F6

0.47

-

F7

0.63

-

F8

0.90

10

F9

0.92

-

Percentage viability (%)

TLC Fractions

140%

10 µg

24 h

80

72 h

*

60%

*

40%
20%
F1

F2

40

*

*

*

*

* *

*

*

*

*

*

*

*

* *
**

Figure 3. Effect of the bioactive fraction F8 on HeLa cell viability
when treated for 24, 48, and 72 h. Vertical bars indicate SE of the
mean for n = 4.*: P < 0.05 as compared to the control. **: P < 0.01
as compared to the control.

fraction increased, there was a decrease in the percentage
viability of the HeLa cells with an IC50 value of 10 µg/mL.
When lymphocytes were treated with the TLC
separated fractions from A. japonicus, there was
proliferation of lymphocytes from 200% to 295%, which
suggested that these fractions were immunostimulatory/
immunomodulatory in nature just like the crude extracts
from which they were isolated (Figure 4). The percentage
viability was highest in fraction 6 (287.23%) and lowest in
fraction 1 (232.21%) treated lymphocytes. The P value at
both the tested concentrations (10 and 20 µg/mL) was less
than 0.0001, which means that they are highly significant.
3.4. Fluorescence microscopy
To confirm that the bioactive fraction inhibits the
proliferation of HeLa cells by inducing apoptosis in the
cells, fluorescence microscopic studies were carried out. We
350%

100%
80%

60

48 h

0
10
20
40
80
100
Different concentrations (µg/mL) of fraction F8 applied to HeLa cells

20 µg

120%

0%

100

Percentage viability (%)

Percentage viability

Control

control

20

µg/mL (41.82%) concentrations (Figure 2). The IC50 value
was found to be 10 µg/mL for this bioactive fraction. Upon
checking the P value by one way ANOVA, the P value was
found to be 0.0013, which is statistically significant at α =
0.05. This effect was found to be significant compared with
treatments with other fractions of A. japonicus. Treatment
with other fractions did not result in significant changes in
the viability of the HeLa cells. There was proliferation of
HeLa cells by fraction 6 at 10 and 20 µg/mL concentrations
(123.65% and 130%, respectively) and fraction 3 at 20
µg/mL (135.00%). The bioactive fraction F8 was further
tested for its antiproliferative activity on the HeLa cells
by treating them with this fraction for 24, 48, and 72 h.
The results further confirmed the bioactivity of fraction
F8 as shown in Figure 3. The inhibition in the percentage
viability of HeLa cells was dose- and time-dependent.
As the concentration and time of exposure to the active
160%

120

F3
F4
F5
F6
F7
F8
Different fractions separated in TLC

F9

Figure 2. Effect of the TLC purified fractions (F1–F9) at 10 and
20 µg/mL concentrations on HeLa cell viability. Vertical bars
indicate SE of the mean for n = 4. *: P < 0.05 as compared to the
control.

Control
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300%
250%
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100%
50%
0%
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F3

F4

F5

F6

F7

F8

F9

Different samples applied to lymphocytes

Figure 4. Effect of the crude extract and the TLC purified fractions
(F1–F9) on the percentage viability of normal lymphocytes.
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observed that the untreated control HeLa cells were round
and greenish orange, with a higher cell concentration as
shown in Figure 5a. Apoptotic bodies were seen as deep
reddish bodies with blebs on the cell surfaces as compared
to the controls (Figures 5b and 5c). Presence of apoptotic
bodies is characteristic of programmed cell death, which
explains the decrease in the viability of the treated HeLa
cells. From Figures 5b and 5c, it is also clear that the cell
number decreased as the concentration of treatment
increased.
3.5. Caspase-3-apoptosis assay
The activity of caspases, which is known as an important
biochemical feature in apoptotic signaling, was determined
to investigate whether the apoptosis was induced by the
bioactive fraction of the extract. Since caspase-3 is one
of the main downstream effecter caspases that is present
in most cell types and plays an important role in the
execution of apoptotic cell death by cleaving the cellular
substrates, we then compared its activity in treated and
untreated control cells. The result showed that caspase-3
was significantly activated (30%) in the treated cells (Table
2). This confirmed the apoptotic induction of cell death by
this fraction. When one way ANOVA was carried out, the
P value was less than 0.0001, which indicates it to be highly
significant.
3.6. DNA fragmentation assay
The DNA fragmentation was analyzed by 0.8% agarose
gel electrophoresis (Figure 6). When the DNA isolated
from the treated cells was subjected to agarose gel
electrophoresis, a DNA smear characteristic of apoptotic
DNA was observed. However, the DNA extracted from
the control cells appeared as a single band indicating the
presence of intact DNA.
3.7. Chemical screening
Chemical screening was carried out to identify the active
compounds present in the crude extract and the bioactive
fraction. Bioactive fraction F8 indicated the presence of
alkaloids (Table 3).

a

b

3.8. LC- MS analysis
The fraction F8 collected from preparative TLC was further
subjected to LC-MS analysis. By liquid chromatography,
fraction 8 gave 2 peaks when eluting with a reverse phase
C18 column, a larger peak with a retention time of 5.50
min (Figure 7), and a second one with a retention time of
10.40. The mass spectra showed the mass to charge ratio
of the first peak as 819.53 and that of the second peak as
693.8. These values did not correspond to the molecular
weight of any of the earlier reported fungal metabolites
(Neilsen and Smedsgaard, 2003) or any reported from
Aspergillus species (Bladt et al., 2013).
4. Discussion
In the past 50 years, a number of highly successful
drugs based upon fungal metabolites have been
discovered. Besides producing antibiotics fungi have a
much greater potential for producing other medicinally
useful compounds including ergot alkaloids, steroid
derivatives, antitumor agents, and immunoregulators
(Wainwright, 1992). Among the fungi, filamentous fungi
are unique in producing a wide range of natural products
called secondary metabolites (Bu’Lock, 1961). These
compounds are very diverse in structure and perform
functions that are not always known. However, interest
in these compounds is considerable, as many natural
products are of medical, industrial, and/or agricultural
importance (Demain and Fang, 2000). In our search for
novel compounds with anticancer potential, we isolated
Aspergillus japonicus from a soil source in Bangalore, and
extracted the secondary metabolites using methanol as the
solvent. When we screened our isolate for cytotoxicity on
HeLa cells and on normal lymphocytes, we found that the
bioactive fraction from A. japonicus had high anticancer
and antiproliferative effects with an IC50 value of 10 µg/
mL. The crude extract and the bioactive fraction from this
have both exhibited immunostimulatory effects on normal
human lymphocytes. It was reported that (Sudarmono et
al., 2006), the secondary metabolite extracted from an

c

Figure 5. Fluorescence microscopy. 5a. Control HeLa cells. 5b. HeLa cells treated with 10 µg/mL of fraction F8. 5c.
HeLa cells treated with 20 µg/mL of fraction F8. Arrows indicate fragmented nucleus in apoptotic cells. Note the fewer
cells in higher concentration of extract treatment.
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Table 2. Percentage activity of caspase-3 enzyme in HeLa cells
treated with F8 as compared to the controls.

Table 3. Preliminary chemical screening of the fungal extract
and the bioactive fraction F8.

Sample

OD

Percentage

Chemicals screened

Crude extract

Purified extract (F8)

Control

0.078

42.16

Alkaloids

+

+

F8

0.134

72.43

Steroids

+

-

Blank

0

0

Reducing sugars

+

-

Tannins

-

-

Saponins

-

-

Flavonoids

-

-

Proteins

+

-

Phenols

-

-

Glycosides

+

-

endophytic fungus exhibited an IC50 value of 361.21 µg/mL
on HeLa cells after 24 h and an IC50 of 219.97 µg/mL after
48 h. The IC50 of Kuanoniamine C (which is an anticancer
compound) was 5.1 µg/mL on HeLa cells as reported by
Sawada et al. (2005). The extract from our isolated fungi
seems to have more potent cytotoxicity when compared to
these earlier reports.
Apoptosis, or programmed cell death, is a biological
process that maintains homeostasis in the body tissues.
The apoptotic features associated with cell death are cell
shrinkage, chromatin condensation, internucleosomal
DNA fragmentation, and formation of apoptotic bodies.
Our fluorescence microscopic studies confirmed the
formation of apoptotic bodies when treated with the
bioactive fraction. This fraction was harmless on normal
lymphocytes and allowed them to proliferate. As seen by
their MTT assay on lymphocytes, the percentage viability
Lanes

1

2

3

4

Figure 6. DNA fragmentation analysis of HeLa cells treated with
the bioactive fraction F8. Lanes 1. DNA ladder. 2. DNA from
HeLa cells treated with 20 µg/mL of F8. 3. DNA from HeLa cells
treated with 10 µg/mL of F8. 4. DNA from control HeLa cells.

was more than 100%, which confirmed their proliferation.
The best was found to be F8, which reduced the percentage
viability of HeLa cells to 50.1% at 10 µg/mL and 41% at 20
µg/mL concentrations. This fraction was used for further
studies. The bioactive fraction F8 was further checked for
its ability to induce apoptosis in the cervical cancer cell
line HeLa by the caspase-3 activity assay. Caspases are a
class of cysteine processes, of which caspase-3 is member
of the caspase family and is the one of the key executioners
of apoptosis, and is partially or totally responsible for
the proteolytic cleavage of many proteins. In our study,
caspase-3 activity of the treated HeLa cells was 30%
higher than that of the untreated control cells after 24 h
of treatment. The results of DNA fragmentation analysis,
where we observed DNA smears in the treated HeLa
cells as opposed to the intact DNA of controls, indicated
clearly the apoptotic induction of cell death in the treated
HeLa cells. Hence, it is certain that the bioactive fraction
induced apoptosis in the cervical cancer cell line.
Chemical analysis is required to identify the chemical
groups to which the bioactive secondary metabolite
belongs. Usually, the bioactive metabolites that are present
in most fungi include phenolic compounds, flavonoids,
and polysaccharides (Teoh et al., 2013). However, the
preliminary chemical screening of our fungal bioactive
compound suggested that the active component was
alkaloid in nature. Furthermore, this fraction (F8) was
subjected to characterization studies by LC-MS analysis.
The mass to charge ratio was 819.53 for the active
compound and 693.8 for the other one. As these values
are not reported earlier for any anticancer compound
of fungal origin, they appear to be novel. To the best of
our knowledge, this is the first report of any anticancer
compound from A. japonicus. This compound has the
potential to serve as a source of antineoplastic agent,
without killing the normal healthy lymphocytes.
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Figure 7. LC-MS analysis of TLC purified fraction F8 of the fungal extract: (a) HPLC
chromatogram of fraction F8 showing 2 peaks, one at RT 5.50 and second smaller peak
at RT 10.40. (b) LC-MS spectra of the first fraction, m/z 819.53 (c) LC-MS spectra of the
second fraction, m/z 693.80.
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Through this study, A. japonicus was found to be
an excellent source for the production of a secondary
metabolite with a unique cytotoxic property against the
cervical cancer cell line HeLa, which could be easily purified
to yield a compound having the potential to function as an
antineoplastic agent. Further characterization and animal
studies are required to confirm this, which are currently
being undertaken in our laboratory.
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